Members of private health insurer Health Insurance Fund (HIF) will be given priority access to Little Green Pharma (ASX: LGP) and their research into medicinal cannabis with the two commencing a strategic partnership focused on improving patient quality of life. Under the partnership, HIF members will be given priority participation in Little Green Pharma product
Read More
Medicinal cannabis company Creso Pharma (ASX: CPH) is continuing to see strong international interest in their premium cannabis flowers with an order worth $930k placed from repeat Israeli client Univo Pharmaceuticals Ltd (TLV: UNVO). The larger order for premium, cured and hand-trimmed dried medicinal cannabis flower follows on from an order for $820k of the
Read More
In preparation for legislative changes which may soon see cannabis products purchasable over the counter without a prescription, leading medicinal cannabis product manufacturer THC Global (ASX: THC) has partnered with Cannatrek to produce white-labeled CBD products at their high-volume Southport facility in Queensland. As a sizable grower of medicinal cannabis with a diverse range of
Read More
As part of their plans to collaborate with the NRL on concussion solutions, Impression Healthcare (ASX: IHL) has appointed NRL star James Graham to its advisory board to assist with the development of their medicinal cannabis products. In particular, Graham will offer advice on ‘real world’ aspects of the clinical program for IHL-216A, a cannabinoid
Read More
Cannabis healthcare company Bod Australia (ASX: BDA) has commenced its penetration of the lucrative UK medicinal cannabis market having received its first international prescriptions for their MediCabilis™ product. With more than 7.3 million consumers of cannabis products in the UK annually, it represents a major addressable market for Bod which estimates its value to be
Read More
Australian medicinal cannabis and healthcare company Little Green Pharma (ASX: LGP) has this morning announced a key purchase agreement with Berlin-based DEMECAN for the sale and export of up to 1000kg of dried cannabis flower or 48,000 units of medicinal cannabis per annum. The agreement makes LGP one of the first few companies to export
Read More